MF101: a multi-component botanical selective estrogen receptor beta modulator for the treatment of menopausal vasomotor symptoms

Author： Leitman Dale C   Christians Uwe  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.7, 2012-07, pp. : 1031-1042

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tissue-Selective Estrogen Complex Bazedoxifene and Conjugated Estrogens for the Treatment of Menopausal Vasomotor Symptoms

By Stovall Dale W.   Tanner-Kurtz Kirby   Pinkerton JoAnn V.  

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1649-1657

Adis International

Access to resources Recommend Favorite

The selective estrogen receptor modulator CHF 4227 appears to be effective and well-tolerated in the treatment of postmenopausal women

By  

Inpharma, Vol. 1, Iss. 1609, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Menopausal hormone therapy for vasomotor symptoms: balancing the risks and benefits with ultra-low doses of estrogen

By Simon James A   Snabes Michael C  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 2005-2020

Informa Healthcare

Access to resources Recommend Favorite

Tissue-Selective Estrogen Complexes: A Promising Option for the Comprehensive Management of Menopausal Symptoms

By Archer David F.  

Drugs & Aging, Vol. 27, Iss. 7, 2010-07 ,pp. : 533-544

Adis International

Access to resources Recommend Favorite

Selective Estrogen Receptor Modulator Medicinal Chemistry At Merck. A Review

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 9, 2008-06 ,pp. : 792-812

Bentham Science Publishers

Access to resources Recommend Favorite